Preparing for Quality Payment Program Year Four
(NOTE: This is a longer version of an article that appeared in the May 2020 issue of Vascular Specialist.)
With the confounding issues facing healthcare c-suites today, it can be difficult to impress how the Vascular Verification Program works strategically to improve outcomes for the patient and hospital by prioritizing efforts to increase effective and efficient delivery of care—reducing risk for post-operative negative consequences.
Please download this PowerPoint to help facilitate the conversation or contact SVSQuality@vascularsociety.org to schedule a consultation with one of our SVS Vascular Verification leaders to discuss working with your c-suite.
The American College of Surgeons (ACS), in collaboration with the Society for Vascular Surgery (SVS), proudly presents the Vascular Verification Program—a national quality verification program designed to support the ongoing advancement and long-term sustainability of care for patients receiving vascular surgical and interventional services in the inpatient setting.
Since its inception, over a dozen centers nationwide have achieved verification, reflecting both the program’s rigorous standards and growing national momentum among leading institutions committed to sustained excellence in vascular care.
Recognizing the complexity and breadth of vascular care, the program provides an enduring, evidence-driven framework that supports both the development and continuous maturation of quality improvement and clinical care infrastructure over time.
With two levels of participation, the Vascular Verification Program engages centers across the spectrum of care—offering a structured pathway to:
By supporting continuous improvement, the program helps ensure a lasting impact on patient outcomes and program performance.
Albany Medical Center – Inpatient and Outpatient
Ascension St. Vincent Indianapolis Hospital
Baylor Scott & White The Heart Hospital – Dallas
Baylor Scott & White The Heart Hospital – Plano
Corewell Health Butterworth Hospital
Froedtert and the Medical College of Wisconsin Froedtert Hospital
Keck Hospital of USC
Memorial Regional Hospital
Michigan Vascular Center
Rochester General Hospital
St. Mary Hospital and Medical Center
UCSF Medical Center
University of Tennessee Medical Center
Vascular Institute of New York
WellSpan York Hospital
Become a Vascular-VP Center
As a program uniquely focused on the care of vascular surgical and interventional patients in an inpatient setting, the Vascular Verification Program offers an opportunity to chart the progress of your center's program while also setting benchmarks and goals to continue the quality improvement journey of vascular science.
If you have questions about the Vascular Verification Program, please contact us at vascular@facs.org.
(NOTE: This is a longer version of an article that appeared in the May 2020 issue of Vascular Specialist.)
The new abdominal aortic aneurysm (AAA) guidelines are some of the most extensive ever developed by the Society for Vascular Surgery, with 112 recommendations and 774 supporting references.
The SVS Patient Safety Organization has announced the winners of the 2016 VQI Participation Awards. This program, in its second year, recognizes the importance of active participation in the VQI as a critical component of the quality improvement mission.
CHICAGO, Illinois – A new Vascular Medicine Registry will be launched in early 2017 by the Society for Vascular Surgery (SVS) and the Society for Vascular Medicine (SVM).
Dr. Jens Eldrup-Jorgensen has been named the new medical director of the Society for Vascular Surgery Patient Safety Organization (SVS PSO).
As of mid-December, researchers have activated the first 10 medical sites and enrolled the first nine patients in a study that will determine the safety and effectiveness of inferior vena cava filters, small, cage-like devices implanted to prevent life-threatening blood clots from reaching the heart or lungs. While vein filters have been in use for years, PRESERVE (Predicting the Safety and Effectiveness of Inferior Vena Cava Filters), is the first large-scale, multispecialty, prospective clinical research trial that will evaluate their real world safety and effectiveness. The inferior vena cava is the main vessel returning blood from the lower half of the body to the heart.